{"title":"鲸类动物中红喉丹毒的发生、流行病学和疫苗反应:基于两次全球调查的30年回顾性研究。","authors":"Geraldine Lacave, E Cox","doi":"10.3354/dao03862","DOIUrl":null,"url":null,"abstract":"<p><p>Erysipelas, an infection caused by Erysipelothrix rhusiopathiae, has always been a threat to marine mammal collections. A first global survey (1989-2000) about erysipelas occurrences, covering 1384 animals, reported 69 cases of erysipelas (5%). To better understand the disease epidemiology and vaccine-related reactions, a second survey (2001-2020) was conducted, reaching a 68.6% response rate (140/204 facilities) and including 2267 cetaceans. It reported 108 cases (4.8%), with more than 5 cases annually and a 50% fatality rate. At least 1 case was reported in 40% of responding facilities, all involving non-vaccinated animals or those vaccinated only once or twice. Most facilities began vaccinating after experiencing a case, while fear of adverse fatal anaphylaxis reaction remains the primary reason for avoiding it. Notably, only 1 fatal vaccine reaction was reported in 1989, though procaine penicillin had been co-administered. Adverse reactions were rare and mostly resembled expected inflammatory reactions post vaccination such as anorexia, local swelling or blood changes. These were more frequent with oil-adjuvanted vaccines containing alpha-tocopherol or Amphigen®, and minimal to absent with aluminum hydroxide-based vaccines. Three facilities using the Amphigen®-adjuvanted ER Bac® Plus vaccine (Zoetis) observed transient lethargy and irregular breathing in 8 animals after several vaccinations, of which 1 had been treated. Regional differences in vaccine availability were observed. This 30 yr retrospective study highlights that cetaceans in human care face a greater risk of dying from erysipelas than from vaccine side effects. Furthermore, regular vaccination appears to offer effective protection against this preventable disease.</p>","PeriodicalId":11252,"journal":{"name":"Diseases of aquatic organisms","volume":"163 ","pages":"63-78"},"PeriodicalIF":1.2000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Erysipelothrix rhusiopathiae occurrence, epidemiology and vaccine reactions in cetaceans: a thirty-year retrospective based on two global surveys.\",\"authors\":\"Geraldine Lacave, E Cox\",\"doi\":\"10.3354/dao03862\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Erysipelas, an infection caused by Erysipelothrix rhusiopathiae, has always been a threat to marine mammal collections. A first global survey (1989-2000) about erysipelas occurrences, covering 1384 animals, reported 69 cases of erysipelas (5%). To better understand the disease epidemiology and vaccine-related reactions, a second survey (2001-2020) was conducted, reaching a 68.6% response rate (140/204 facilities) and including 2267 cetaceans. It reported 108 cases (4.8%), with more than 5 cases annually and a 50% fatality rate. At least 1 case was reported in 40% of responding facilities, all involving non-vaccinated animals or those vaccinated only once or twice. Most facilities began vaccinating after experiencing a case, while fear of adverse fatal anaphylaxis reaction remains the primary reason for avoiding it. Notably, only 1 fatal vaccine reaction was reported in 1989, though procaine penicillin had been co-administered. Adverse reactions were rare and mostly resembled expected inflammatory reactions post vaccination such as anorexia, local swelling or blood changes. These were more frequent with oil-adjuvanted vaccines containing alpha-tocopherol or Amphigen®, and minimal to absent with aluminum hydroxide-based vaccines. Three facilities using the Amphigen®-adjuvanted ER Bac® Plus vaccine (Zoetis) observed transient lethargy and irregular breathing in 8 animals after several vaccinations, of which 1 had been treated. Regional differences in vaccine availability were observed. This 30 yr retrospective study highlights that cetaceans in human care face a greater risk of dying from erysipelas than from vaccine side effects. Furthermore, regular vaccination appears to offer effective protection against this preventable disease.</p>\",\"PeriodicalId\":11252,\"journal\":{\"name\":\"Diseases of aquatic organisms\",\"volume\":\"163 \",\"pages\":\"63-78\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diseases of aquatic organisms\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.3354/dao03862\",\"RegionNum\":4,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"FISHERIES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diseases of aquatic organisms","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.3354/dao03862","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"FISHERIES","Score":null,"Total":0}
Erysipelothrix rhusiopathiae occurrence, epidemiology and vaccine reactions in cetaceans: a thirty-year retrospective based on two global surveys.
Erysipelas, an infection caused by Erysipelothrix rhusiopathiae, has always been a threat to marine mammal collections. A first global survey (1989-2000) about erysipelas occurrences, covering 1384 animals, reported 69 cases of erysipelas (5%). To better understand the disease epidemiology and vaccine-related reactions, a second survey (2001-2020) was conducted, reaching a 68.6% response rate (140/204 facilities) and including 2267 cetaceans. It reported 108 cases (4.8%), with more than 5 cases annually and a 50% fatality rate. At least 1 case was reported in 40% of responding facilities, all involving non-vaccinated animals or those vaccinated only once or twice. Most facilities began vaccinating after experiencing a case, while fear of adverse fatal anaphylaxis reaction remains the primary reason for avoiding it. Notably, only 1 fatal vaccine reaction was reported in 1989, though procaine penicillin had been co-administered. Adverse reactions were rare and mostly resembled expected inflammatory reactions post vaccination such as anorexia, local swelling or blood changes. These were more frequent with oil-adjuvanted vaccines containing alpha-tocopherol or Amphigen®, and minimal to absent with aluminum hydroxide-based vaccines. Three facilities using the Amphigen®-adjuvanted ER Bac® Plus vaccine (Zoetis) observed transient lethargy and irregular breathing in 8 animals after several vaccinations, of which 1 had been treated. Regional differences in vaccine availability were observed. This 30 yr retrospective study highlights that cetaceans in human care face a greater risk of dying from erysipelas than from vaccine side effects. Furthermore, regular vaccination appears to offer effective protection against this preventable disease.
期刊介绍:
DAO publishes Research Articles, Reviews, and Notes, as well as Comments/Reply Comments (for details see DAO 48:161), Theme Sections and Opinion Pieces. For details consult the Guidelines for Authors. Papers may cover all forms of life - animals, plants and microorganisms - in marine, limnetic and brackish habitats. DAO''s scope includes any research focusing on diseases in aquatic organisms, specifically:
-Diseases caused by coexisting organisms, e.g. viruses, bacteria, fungi, protistans, metazoans; characterization of pathogens
-Diseases caused by abiotic factors (critical intensities of environmental properties, including pollution)-
Diseases due to internal circumstances (innate, idiopathic, genetic)-
Diseases due to proliferative disorders (neoplasms)-
Disease diagnosis, treatment and prevention-
Molecular aspects of diseases-
Nutritional disorders-
Stress and physical injuries-
Epidemiology/epizootiology-
Parasitology-
Toxicology-
Diseases of aquatic organisms affecting human health and well-being (with the focus on the aquatic organism)-
Diseases as indicators of humanity''s detrimental impact on nature-
Genomics, proteomics and metabolomics of disease-
Immunology and disease prevention-
Animal welfare-
Zoonosis